Gene Therapy

Latest News

Avirmax Biopharma Inc receives IND approval from FDA
Avirmax Biopharma Inc receives IND approval from FDA

June 6th 2024

The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration (AMD) including Polypoidal Choroidal Vasculopathy (PCV).

Data and Safety Monitoring Board approves simultaneous enrollment in Cohort 3 and Phase 2 initiation in OCU410 ArMaDa study for GA
Data and Safety Monitoring Board approves simultaneous enrollment in Cohort 3 and Phase 2 initiation in OCU410 ArMaDa study for GA

June 1st 2024

Prevent Blindness offering resources for education, to raise awareness for Stargardt disease
Prevent Blindness offering resources for education, to raise awareness for Stargardt disease

May 21st 2024

Study: High-frequency electrical ‘noise’ may result in congenital night blindness
Study: High-frequency electrical ‘noise’ may result in congenital night blindness

May 21st 2024

New therapeutic targets, drug development for RP
New therapeutic targets, drug development for RP

May 16th 2024

Video Interviews
Podcasts
Latest CME Events & Activities

Road Mapping the Treat and Extend Protocol in nAMD and DME – When Time is Sight

June 27, 2024

View More

17th Annual Controversies in Modern Eye Care

View More

(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care

View More

(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care

View More

(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon

View More

The Ins and Outs of Lubricating Eye Drops

View More

What’s New in MGD Beyond Heating and Squeezing?

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection

View More

Modern-izing Retina

September 4 - 5, 2024

View More

Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)

View More

Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden

View More

Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data

View More

Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)

View More

EyeCon 2024

September 27-28, 2024

Register Now!

Join us after AAO for a CME session | In-Person + Virtual

October 19, 2024

Register Now!

(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

View More

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)

View More

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)

View More

(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

View More

Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data

View More

Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME

View More

(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium

View More

(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape

View More

(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment

View More

(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon

View More

More News

© 2024 MJH Life Sciences

All rights reserved.